SOAT1 and Arthritis: In their mechanisms of inhibition (MOIs), JAKi are widely used to treat arthritis because they block JAK/STAT signaling and reduce the downstream production of inflammatory cytokines and limit the activation of synovial fibroblasts, which are key effectors of persistent joint inflammation (66) (Table 1).